Skip to main content
. 2023 Aug 17;4(10):100559. doi: 10.1016/j.jtocrr.2023.100559

Table 2.

Breakdown of Treatment-Related Pneumonitis Incidence by Grade According to Common Terminology Criteria for Adverse Events Version 5.0

Pneumonitis Grade Category Total (N = 102) Osimertinib Overlapping (n = 22) Osimertinib Held During RT (n = 80)
None or grade 1 88 (86.3) 20 (90.9) 68 (85.0)
Grade 2+ 14 (13.7) 2 (9.1) 12 (15.0)
Pneumonitis by grade
 None 86 (84.3) 18 (81.8) 68 (85.0)
 Grade 1 2 (2.0) 2 (9.0) 0 (0.0)
 Grade 2 9 (8.8) 1 (4.6) 8 (10.0)
 Grade 3 3 (2.9) 1 (4.6) 2 (2.5)
 Grade 4 0 (0.0) 0 (0.0) 0 (0.0)
 Grade 5 2 (2.0) 0 (0.0) 2 (2.5)
Time to grade 2+ pneumonitis, median [range] in mo 3.2 [1.5–6.3] 2.2 [1.6–2.7] 3.4 [1.5–6.3]

Note: All values are n (%) unless otherwise specified.

RT, radiotherapy.